Skip to content

Effects of Chocolate on Coronary Vasomotion in Patients After Heart Transplantation

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00521573
Enrollment
Unknown
Registered
2007-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2007-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Transplantation

Brief summary

The aim of the present study is to investigate whether the ingestion of a flavonoid-rich dark chocolate compared to flavonoid-free placebo chocolate will improve coronary vasomotion in heart transplanted patients.

Detailed description

Dark chocolate contains a high amount of flavonoids. Flavonoids hold the possibilities to improve oxidative stress and hence the possibility to improve endothelium-dependent coronary vasomotion, which is a powerful surrogate for clinical prognosis. Coronary atherosclerosis is promoted by impaired endothelial function and increased platelet activation. High oxidative stress and reduced antioxidant defenses play a crucial role in the pathogenesis of atherosclerosis, in particular in transplanted hearts. The aim of the present study is to investigate whether the ingestion of a flavonoid-rich dark chocolate compared to flavonoid-free placebo chocolate will improve coronary vasomotion in heart transplanted patients.

Interventions

OTHERDark chocolate

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years

Inclusion criteria

1. Patients after heart transplantation not requiring immediate coronary intervention 2. Age 20 - 80 3. Written obtained informed consent

Exclusion criteria

1. Heart failure (acute or chronic \>NYHA II) 2. Ventricular tachy-arrythmias or AV-Block \>I° 3. Renal insufficiency (\>200 μmol/l) or liver disease (ALT or AST \>150 IU) 4. Symptomatic hypotension, hypertension \>160/100mmHg 5. Known allergy to compounds dark chocolate 6. Acute infectious disease 7. Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn) 8. Participation in another study within the last month 9. Concomitant vitamin supplements

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026